LCB Trademark

Trademark Overview


On Tuesday, December 24, 2024, a trademark application was filed for LCB with the United States Patent and Trademark Office. The USPTO has given the LCB trademark a serial number of 98921341. The federal status of this trademark filing is REGISTERED as of Tuesday, January 6, 2026. This trademark is owned by LigaChem Biosciences Inc.. The LCB trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development, namely, pharmaceutical drug development services in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and p...
lcb

General Information


Serial Number98921341
Word MarkLCB
Filing DateTuesday, December 24, 2024
Status700 - REGISTERED
Status DateTuesday, January 6, 2026
Registration Number8091682
Registration DateTuesday, January 6, 2026
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 21, 2025

Trademark Statements


Indication of Colors claimedThe color(s) brown is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of vaccines and medicines; biomedical research services; biological research and analysis; research of crude drugs; biochemical research and analysis; bacteriological research and analysis; drug discovery services; Research and development in the field of pharmaceuticals and biotechnology; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; laboratory research in the field of pharmaceuticals; research on the subject of pharmaceuticals; drug development, namely, pharmaceutical drug development services in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; pharmaceutical research and development; pharmaceutical drug development services; consultancy pertaining to pharmacology; medical and pharmaceutical research services; research in the field of medical preparations; medical research laboratory services; medicine research, namely, medical research services relating to medicines in the fields of cancer, oncological disorders, autoimmune diseases, inflammatory diseases, fibrotic diseases and infectious diseases; providing PAAS (platform as a service) featuring computer software used to conduct research and development in the field of pharmaceuticals, biotechnology and drugs; laboratory research services relating to pharmaceuticals; Technology research in the field of medical instruments; testing of pharmaceuticals; medical and scientific research, namely, conducting clinical trials for others; chemical research and analysis
Description of MarkThe mark consists of the stylized letters "LCB" in the color brown.
Pseudo MarkLIGACHEM BIOSCIENCES

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 24, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameLigaChem Biosciences Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressYuseong-gu, Daejeon 34002
KR

Party NameLigaChem Biosciences Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressYuseong-gu, Daejeon 34002
KR

Party NameLigaChem Biosciences Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressYuseong-gu, Daejeon 34002
KR

Trademark Events


Event DateEvent Description
Tuesday, December 24, 2024NEW APPLICATION ENTERED
Tuesday, June 3, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, June 10, 2025ASSIGNED TO EXAMINER
Wednesday, July 9, 2025NON-FINAL ACTION WRITTEN
Wednesday, July 9, 2025NON-FINAL ACTION E-MAILED
Wednesday, July 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, September 16, 2025TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, September 16, 2025CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 16, 2025TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, September 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 15, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 21, 2025PUBLISHED FOR OPPOSITION
Tuesday, October 21, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, October 20, 2025TEAS POST PUBLICATION AMENDMENT RECEIVED
Friday, December 5, 2025ASSIGNED TO PETITION STAFF
Friday, December 5, 2025POST PUBLICATION AMENDMENT - ENTERED
Tuesday, December 16, 2025NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, December 18, 2025NOTICE OF ALLOWANCE CANCELLED
Thursday, December 18, 20251(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, January 6, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, January 6, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED